MicrobiomeTrials
  • Search Trials
  • Conditions
  • Learn
  • About
Data source: ClinicalTrials.gov
This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Sign up for updates
Loading filters…
Showing 395 trials for C. difficile
REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTsRecruiting
DysbiosisClostridium DifficilePet-Human BondingAntibiotic-Associated Colitis
Antimicrobial therapy can lead to disruption of the gut microbiome and infection with Clostridioides difficile, a diseas…
Philadelphia, United StatesEst. completion Sep 1, 2026
View Trial →
Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis PopulationPhase 1Recruiting
Ulcerative ColitisInflammatory Bowel DiseasesClostridioides Difficile Infection
This is a multi-centre, randomised controlled trial comparing fecal microbiota transplantation to placebo in an expanded…
Calgary, CanadaEst. completion Mar 1, 2028
View Trial →
Lifestyle and Recurrent Clostridioides Difficile Infection (CDI)Recruiting
Clostridioides Difficile Infection
This study aims to evaluate the impact of diet on the gut microbiome in adults with Clostridioides difficile infection (…
Ann Arbor, United StatesEst. completion Jun 2027
View Trial →
Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal AntibodyPhase 2Recruiting
Clostridioides Difficile Infection
The purpose of this study is to evaluate the efficacy and safety of AZD5148 for prevention of recurrence of Clostridioid…
Phoenix, United StatesEst. completion Apr 20, 2027
View Trial →
VE303 for Prevention of Recurrent Clostridioides Difficile InfectionPhase 3Recruiting
Clostridium DifficileClostridium Difficile InfectionsClostridium Difficile Infection RecurrenceClostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceCDIC. Diff InfectionRecurrent Clostridium Difficile InfectionC.Difficile DiarrheaDiarrhea Infectious
The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (…
Huntsville, United StatesEst. completion Jun 2027
View Trial →
Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First RecurrencePhase 3Recruiting
Clostridioides Difficile Infection
The clinical trial aims to evaluate the efficacy of fecal microbiota transplantation (FMT) after standard of care treatm…
Basel, SwitzerlandEst. completion Apr 1, 2027
View Trial →
A Screening and Recruitment Study in Adults Expressing Interest in the Emory Microbiota Enrichment ProgramSUSPENDED
Clostridium Difficile Infection
The goal of this study is to rapidly identify subjects who are eligible for the Microbiota Enrichment Program (MEP) at E…
Atlanta, United StatesCompleted Jan 2028
View Trial →
Role of Bile Acids and Microbiota in Clostridioides Difficile Infection in Ulcerative ColitisRecruiting
Ulcerative Colitis
Ulcerative Colitis (UC) is a chronic Inflammatory Bowel Disease characterized by chronic inflammation of the colon. Comp…
Paris, FranceEst. completion Jun 2029
View Trial →
C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.Recruiting
Clostridioides Difficile Infection Recurrence
Hospitals and clinics interested in participating in this multi-site study, please contact the people mentioned under "C…
Atlanta, United StatesEst. completion Oct 15, 2026
View Trial →
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderPhase 3Recruiting
Clostridioides Difficile Associated Disease
The purpose of the study is to learn about how effective, safe, and tolerable the Clostridioides difficile (C. difficile…
Athens, United StatesEst. completion Dec 11, 2028
View Trial →
Stress Ulcer Prophylaxis in the Intensive Care UnitPhase 4Completed
Gastrointestinal BleedingStress Ulcers
Stress ulcer prophylaxis (SUP) is standard of care in the intensive care unit (ICU), however the quantity and quality of…
Aalborg, DenmarkCompleted Oct 22, 2017
View Trial →
Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk PatientsPhase 1Recruiting
Clostridioides Difficile InfectionRecurrent Infection
Clostridioides difficile infection (CDI) is the leading cause of nosocomial diarrhea in Europe, with over 120,000 cases …
Annecy, FranceEst. completion Jan 7, 2027
View Trial →
Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only TreatmentRecruiting
Clostridioides Difficile Infection
The goal of this observational study is to learn about the long-term effects of fecal microbiota transplantation (FMT) c…
Umeå, SwedenEst. completion Aug 1, 2026
View Trial →
Evaluation of GeoHAI ImplementationRecruiting
Clostridioides Difficile InfectionHealthcare Associated Infection
Geographic Information Systems (GIS) and spatial analysis have become important tools in public health informatics but h…
Columbus, United StatesEst. completion Apr 1, 2026
View Trial →
Animal-Assisted Visitation Program Chlorhexidine TrialPhase 4Completed
Methicillin-resistant Staphylococcus AureusClostridium DifficilePseudomonas Aeruginosa
Hospital-based Animal-Assisted visitation programs are important complementary therapies, but concerns with infection co…
Baltimore, United StatesCompleted Sep 1, 2025
View Trial →
Vancomycin Taper to Prevent Recurrent Clostridioides DifficilePhase 3Recruiting
Clostridia Difficile Colitis
Indirect evidence from network meta-analyses of randomized controlled trials (RCTs) suggest that a pulse and taper (P-T)…
Montreal, CanadaEst. completion Jun 1, 2030
View Trial →
Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard TherapyEARLY_PHASE1Recruiting
Clostridioides Difficile Infection
The goal of this clinical trial is to determine whether Ursodeoxycholic Acid (UDCA) can help prevent recurrence of Clost…
Milwaukee, United StatesEst. completion May 1, 2027
View Trial →
To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy AdultsPhase 1Recruiting
Clostridoides Difficile Associated Disease
An antibody is a substance your body makes to fight off infection. This study will explore the safety and antibody respo…
Phoenix, United StatesEst. completion Jun 19, 2031
View Trial →
FMT Capsules for rCDIPhase 3Recruiting
Clostridioides Difficile Infection RecurrenceFMT
Double blind RCT study of tretment of recurrent Clostridioides difficile infection by FMT capsules.
Helsinki, FinlandEst. completion Dec 31, 2029
View Trial →
A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile InfectionPhase 3Completed
Clostridium Difficile Infection Recurrence
This trial will be initiated to explore whether RBX2660 (REBYOTA®) could be suitable for administration by the practice …
North Little Rock, United StatesCompleted Jan 17, 2025
View Trial →
← PreviousPage 1 of 20Next →
Recruitment Status